NASDAQ · Medical - Devices

Sight Sciences, Inc. (SGHT) Stock

$8.89 +4.96% NASDAQ: SGHT Healthcare

Valuation

MetricValue
Price$8.89
Market Cap$483.70M
P/E Ratio-15.28
P/B Ratio8.79
P/S Ratio5.57
EPS (TTM)$-0.74
52-Week High$9.71
52-Week Low$3.19
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-50.64%
ROA-28.37%
ROCE-33.04%
Gross Margin-48.05%
Operating Margin-48.05%
Net Margin-35.69%
Debt/Equity0.79
Current Ratio10.27

Annual Financials (USD)

Metric20212022202320242025
Revenue$49.0M$71.0M$81.0M$80.0M$77.0M
Operating Profit$-51.0M$-84.0M$-57.0M$-51.0M$-37.0M
Net Profit$-63.0M$-86.0M$-56.0M$-52.0M$-38.0M
EPS$-1.33$-1.80$-1.14$-1.03$-0.74
Op Margin-105.2%-117.7%-70.7%-63.3%-48.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$280.0M$213.0M$167.0M$143.0M$115.0M
Total Liabilities$48.0M$53.0M$46.0M$55.0M$51.0M
Cash$261.0M$185.0M$138.0M$120.0M$92.0M
Borrowings$34.0M$35.0M$35.0M$40.0M$41.0M

Latest News

Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewswire · Jul 22, 2026 Discover 3 Promising Penny Stocks With Market Caps Over $20M Simply Wall St. · Jun 9, 2026 Sight Sciences Q1 Earnings Call Highlights MarketBeat · May 7, 2026 Sight Sciences, Inc. Q1 2026 Earnings Call Summary Moby · May 7, 2026 Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates Zacks · May 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-53.0M$-76.0M$-47.0M$-22.0M$-30.0M
Investing Cash Flow$-2.0M$-2.0M$-2.0M$-1.0M$0
Financing Cash Flow$-4.0M$0$0$0$0
Net Cash Flow$199.0M$-76.0M$-47.0M$-18.0M$-28.0M
Free Cash Flow$-53.0M$-77.0M$-48.0M$-23.0M$-30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.26
EV / EBITDA-16.56
FCF Yield-5.03%
Quick Ratio4.67
Interest Coverage-10.65
Return 1Y24.34%
Return 3Y-42.96%
Return 5Y-84.93%

Ownership

Insiders Held19.98%
Institutions Held53.59%
Institutions Float Held66.98%
Institutional HolderSharesReport Date
KCK LTD.4,374,9752025-09-30
Long Focus Capital Management, LLC3,594,1002026-03-31
Blackrock Inc.2,831,9322026-03-31
Pathstone Holdings, LLC2,397,3322026-03-31
Americana Partners, LLC1,679,0172026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALCAlcon Inc. $64.11 +1.55% 50.34 $31.27B 0.55%
BHCBausch Health Companies Inc. $6.04 +0.00% -2.08 $2.26B 0.00%
GKOSGlaukos Corporation $165.69 +2.73% -50.38 $9.77B 0.00%
HROWHarrow, Inc. $29.36 -3.80% -30.94 $1.09B 0.00%
IRIXIRIDEX Corporation $0.89 -0.89% -3.16 $15.40M 0.00%

About Sight Sciences, Inc.

Sight Sciences, Inc. is led by CEO Paul Badawi, employs 216 people, headquartered in US, publicly traded since 2021.

Sight Sciences, Inc. (SGHT) stock trades at $8.89 with a market capitalization of $483.70M. The stock is valued at a price-to-earnings (P/E) ratio of -15.28, price-to-book of 8.79, price-to-sales of 5.57. Over the past 52 weeks the stock has ranged between $3.19 and $9.71, and currently trades 8.5% below its 52-week high.

On profitability, Sight Sciences, Inc. generates a return on equity (ROE) of -50.64%, return on capital employed of -33.04%, an operating margin of -48.05%, a net profit margin of -35.69%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides